CDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK manufacturing facility in Stevenage.
The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback